• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补肾活血方治疗卵巢储备功能下降:代谢组学与整合网络药理学联合分析

Bushen Huoxue formula for the treatment of diminished ovarian reserve: A combined metabolomics and integrated network pharmacology analysis.

作者信息

Zeng Pengfei, Zhou Hang, Guo Pei, Han Nana, Zhang Xuan, Yin Zhixing, Xia Wanting, Huang Jinzhu, Zeng Qian

机构信息

Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Heliyon. 2023 Sep 13;9(9):e20104. doi: 10.1016/j.heliyon.2023.e20104. eCollection 2023 Sep.

DOI:10.1016/j.heliyon.2023.e20104
PMID:37809906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10559866/
Abstract

OBJECTIVE

This study aimed to explore the mechanism of the Bushen Huoxue Formula (BHF) in treating diminished ovarian reserve (DOR) through the use of metabolomics and integrated network pharmacology.

METHODS

The study involved 24 non-pregnant female Sprague-Dawley rats, divided into four groups of six rats each: control, model, BHF, and DHEA (n = 6 per group). The model group was induced with DOR by administering Tripterygium glycosides orally [50 mg (kg·d)] for 14 days. Subsequently, BHF and Dehydroepiandrosterone (DHEA) treatments were given to the respective groups. Ovarian reserve function was assessed by measuring anti-Müllerian hormone (AMH), estradiol (E), and follicle-stimulating hormone (FSH) levels and conducting hematoxylin-eosin staining. In addition, UHPLC-QTOF-MS analysis was performed to identify differential metabolites and pathways in DOR rats treated with BHF. In this study, LC-MS was utilized to identify the active ingredients of BHF, while network pharmacology was employed to investigate the correlations between BHF-related genes and DOR-related genes. An integrated analysis of metabonomics and network pharmacology was conducted to elucidate the mechanisms underlying the efficacy of BHF in treating DOR.

RESULTS

The model group exhibited a poor general condition and a significant decrease in the number of primordial, primary, and secondary follicles ( < 0.05) when compared to the control group. However, BHF intervention resulted in an increase in the number of primordial, primary, and secondary follicles ( < 0.05), along with elevated levels of AMH and E ( < 0.05), and a decrease in FSH levels ( < 0.05) in DOR rats. The modeling process identified eleven classes of metabolites, including cholesterol esters (CE), diacylglycerols (DAG), hexosylceramides (HCER), lysophosphatidylcholines (LPC), phosphatidylcholines (PC), phosphatidylethanolamines (PE), sphingomyelins (SM), ceramides (CER), free fatty acids (FFA), triacylglycerols (TAG), and lysophosphatidylethanolamines (LPE). The study found that PC, CE, DAG, and TAG are important metabolites in the treatment of DOR with BHF. LC-MS analysis showed that there were 183 active ingredients in ESI(+) mode and 51 in ESI(-) mode. Network pharmacology analysis identified 285 potential genes associated with BHF treatment for DOR in ESI(+) mode and 177 in ESI(-) mode. The combined analysis indicated that linoleic acid metabolism is the primary pathway in treating DOR with BHF.

CONCLUSION

BHF was found to improve ovarian function in rats with DOR induced by Tripterygium glycosides. The study identified key metabolites such as phosphatidylcholine (PC), cholesteryl ester (CE), diacylglycerol (DAG), triacylglycerol (TAG), and the linoleic acid metabolism pathway, which were crucial in improving ovarian function in DOR rats treated with BHF.

摘要

目的

本研究旨在通过代谢组学和整合网络药理学方法,探讨补肾活血方(BHF)治疗卵巢储备功能下降(DOR)的机制。

方法

本研究选用24只未孕雌性Sprague-Dawley大鼠,分为四组,每组6只:对照组、模型组、BHF组和脱氢表雄酮(DHEA)组(每组n = 6)。模型组通过口服雷公藤多苷[50 mg/(kg·d)]诱导14天建立DOR模型。随后,分别对BHF组和脱氢表雄酮(DHEA)组进行相应处理。通过检测抗苗勒管激素(AMH)、雌二醇(E)和卵泡刺激素(FSH)水平以及苏木精-伊红染色评估卵巢储备功能。此外,采用超高效液相色谱-四极杆飞行时间质谱(UHPLC-QTOF-MS)分析,鉴定BHF治疗DOR大鼠的差异代谢物和代谢途径。本研究利用液相色谱-质谱联用(LC-MS)鉴定BHF的活性成分,同时运用网络药理学研究BHF相关基因与DOR相关基因之间的相关性。进行代谢组学和网络药理学的整合分析,以阐明BHF治疗DOR的疗效机制。

结果

与对照组相比,模型组大鼠一般状况较差,原始卵泡、初级卵泡和次级卵泡数量显著减少(P < 0.05)。然而,BHF干预可使DOR大鼠的原始卵泡、初级卵泡和次级卵泡数量增加(P < 0.05),同时AMH和E水平升高(P < 0.05),FSH水平降低(P < 0.05)。建模过程鉴定出11类代谢物,包括胆固醇酯(CE)、二酰基甘油(DAG)、己糖神经酰胺(HCER)、溶血磷脂酰胆碱(LPC)、磷脂酰胆碱(PC)、磷脂酰乙醇胺(PE)、鞘磷脂(SM)、神经酰胺(CER)、游离脂肪酸(FFA)、三酰基甘油(TAG)和溶血磷脂酰乙醇胺(LPE)。研究发现,PC、CE、DAG和TAG是BHF治疗DOR的重要代谢物。LC-MS分析显示,电喷雾电离正离子(ESI(+))模式下有183种活性成分,电喷雾电离负离子(ESI(-))模式下有51种。网络药理学分析在ESI(+)模式下鉴定出285个与BHF治疗DOR相关的潜在基因,ESI(-)模式下有177个。综合分析表明,亚油酸代谢是BHF治疗DOR的主要途径。

结论

发现BHF可改善雷公藤多苷诱导的DOR大鼠的卵巢功能。本研究鉴定出关键代谢物,如磷脂酰胆碱(PC)、胆固醇酯(CE)、二酰基甘油(DAG)、三酰基甘油(TAG)以及亚油酸代谢途径,这些对于改善BHF治疗的DOR大鼠的卵巢功能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/008a4b6582cc/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/9b369564981a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/999b35950923/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/e0f22a6839d0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/c9fcb2ec0473/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/cc7481388a87/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/008a4b6582cc/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/9b369564981a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/999b35950923/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/e0f22a6839d0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/c9fcb2ec0473/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/cc7481388a87/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/10559866/008a4b6582cc/gr6.jpg

相似文献

1
Bushen Huoxue formula for the treatment of diminished ovarian reserve: A combined metabolomics and integrated network pharmacology analysis.补肾活血方治疗卵巢储备功能下降:代谢组学与整合网络药理学联合分析
Heliyon. 2023 Sep 13;9(9):e20104. doi: 10.1016/j.heliyon.2023.e20104. eCollection 2023 Sep.
2
Protective Effects and Possible Mechanisms of Actions of Bushen Cuyun Recipe on Diminished Ovarian Reserve Induced by Cyclophosphamide in Rats.补肾促孕方对环磷酰胺致大鼠卵巢储备功能下降的保护作用及可能作用机制
Front Pharmacol. 2020 May 13;11:546. doi: 10.3389/fphar.2020.00546. eCollection 2020.
3
Bushen Huoxue formula attenuates lipid accumulation evoking excessive autophagy in premature ovarian insufficiency rats and palmitic acid-challenged KGN cells by modulating lipid metabolism.补肾活血方通过调节脂质代谢减轻卵巢早衰大鼠和棕榈酸刺激的KGN细胞中的脂质积累并引发过度自噬。
Front Pharmacol. 2024 Sep 16;15:1425844. doi: 10.3389/fphar.2024.1425844. eCollection 2024.
4
[Effects of ginger-separated moxibustion at points combined with formula on patients with decreased ovarian reserve function].[隔姜灸穴位联合方剂对卵巢储备功能下降患者的影响]
Zhongguo Zhen Jiu. 2017 Oct 12;37(10):1057-60. doi: 10.13703/j.0255-2930.2017.10.008.
5
Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis.脂槐方通过抑制 PI3K/AKT 介导的细胞凋亡减轻环磷酰胺诱导的卵巢储备功能下降。
J Ethnopharmacol. 2021 Sep 15;277:113789. doi: 10.1016/j.jep.2021.113789. Epub 2021 Jan 7.
6
[Effect of moxibustion pretreatment at different time on ovarian function in rats with dimini-shed ovarian reserve].[不同时间艾灸预处理对卵巢储备功能下降大鼠卵巢功能的影响]
Zhen Ci Yan Jiu. 2019 Nov 25;44(11):817-21. doi: 10.13702/j.1000-0607.190220.
7
Investigation of the Mechanisms and Experimental Verification of Yulin Formula in the Treatment of Diminished Ovarian Reserve via Network Pharmacology.基于网络药理学探讨育麟方治疗卵巢储备功能减退的作用机制及实验验证。
Drug Des Devel Ther. 2023 Jul 24;17:2147-2163. doi: 10.2147/DDDT.S413142. eCollection 2023.
8
Mechanism Research of DHEA Treatment Improving Diminished Ovarian Reserve by Attenuating the AMPK-SIRT1 Signaling and Mitophagy.脱氢表雄酮通过减弱AMPK-SIRT1信号通路和线粒体自噬改善卵巢储备功能下降的机制研究
Reprod Sci. 2024 Jul;31(7):2059-2072. doi: 10.1007/s43032-024-01473-3. Epub 2024 Mar 7.
9
Effects of Bushen Yiqi Huoxue Decoction in Treatment of Patients with Diminished Ovarian Reserve: A Randomized Controlled Trial.补肾益气活血方治疗卵巢储备功能下降患者的效果:一项随机对照试验。
Chin J Integr Med. 2022 Mar;28(3):195-201. doi: 10.1007/s11655-020-3484-x. Epub 2021 Jan 9.
10
Dingkun Pill replenishes diminished ovarian reserve through the PI3K/AKT/mTOR signaling pathway in TWP-induced mice.定坤丹通过 PI3K/AKT/mTOR 信号通路改善雷公藤多苷致卵巢储备功能下降模型小鼠的卵巢储备功能。
J Ethnopharmacol. 2020 Nov 15;262:112993. doi: 10.1016/j.jep.2020.112993. Epub 2020 May 28.

引用本文的文献

1
Bushen Huoxue formula attenuates lipid accumulation evoking excessive autophagy in premature ovarian insufficiency rats and palmitic acid-challenged KGN cells by modulating lipid metabolism.补肾活血方通过调节脂质代谢减轻卵巢早衰大鼠和棕榈酸刺激的KGN细胞中的脂质积累并引发过度自噬。
Front Pharmacol. 2024 Sep 16;15:1425844. doi: 10.3389/fphar.2024.1425844. eCollection 2024.

本文引用的文献

1
Effect of Zhuyun I Recipe Capsule Enema on the Immune Microenvironment of the Endometrium during Implantation Window in Rats.助孕I号方胶囊灌肠对大鼠着床窗期子宫内膜免疫微环境的影响
Emerg Med Int. 2022 Oct 7;2022:4746121. doi: 10.1155/2022/4746121. eCollection 2022.
2
Role of lncRNAs in the pathogenic mechanism of human decreased ovarian reserve.长链非编码RNA在人类卵巢储备功能下降致病机制中的作用
Front Genet. 2023 Feb 8;14:1056061. doi: 10.3389/fgene.2023.1056061. eCollection 2023.
3
Regulation of ovarian function by growth hormone: Potential intervention of ovarian aging.
生长激素对卵巢功能的调节:干预卵巢衰老的潜力。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1072313. doi: 10.3389/fendo.2022.1072313. eCollection 2022.
4
Combined metabolomics and network pharmacology to elucidate the mechanisms of Dracorhodin Perchlorate in treating diabetic foot ulcer rats.结合代谢组学和网络药理学阐明高氯酸钾血竭素治疗糖尿病足溃疡大鼠的机制。
Front Pharmacol. 2022 Nov 18;13:1038656. doi: 10.3389/fphar.2022.1038656. eCollection 2022.
5
Moxibustion alleviates decreased ovarian reserve in rats by restoring the PI3K/AKT signaling pathway.艾灸通过恢复PI3K/AKT信号通路减轻大鼠卵巢储备功能下降。
J Integr Med. 2022 Mar;20(2):163-172. doi: 10.1016/j.joim.2022.01.007. Epub 2022 Jan 31.
6
Treatment Progress in Diminished Ovarian Reserve: Western and Chinese Medicine.卵巢储备功能下降的中西医治疗进展
Chin J Integr Med. 2023 Apr;29(4):361-367. doi: 10.1007/s11655-021-3353-2. Epub 2022 Jan 11.
7
Prevalence and associated factors of infertility among 20-49 year old women in Henan Province, China.中国河南省 20-49 岁女性不孕患病率及相关因素分析。
Reprod Health. 2021 Dec 20;18(1):254. doi: 10.1186/s12978-021-01298-2.
8
Network pharmacology: curing causal mechanisms instead of treating symptoms.网络药理学:从病因机制治疗,而非对症治疗。
Trends Pharmacol Sci. 2022 Feb;43(2):136-150. doi: 10.1016/j.tips.2021.11.004. Epub 2021 Dec 9.
9
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.MetaboAnalyst 5.0:缩小原始光谱与功能见解之间的差距。
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396. doi: 10.1093/nar/gkab382.
10
Sequential therapy for kidney-tonifying via traditional Chinese medicine effectively improves the reproductive potential and quality of life of women with decreased ovarian reserve: a randomized controlled study.中药补肾序贯疗法有效提高卵巢储备功能下降女性的生殖潜能及生活质量:一项随机对照研究
Am J Transl Res. 2021 Apr 15;13(4):3165-3173. eCollection 2021.